MedReleaf Stock Price, News & Analysis (TSE:LEAF)

C$20.40 -1.60 (-7.27 %)
(As of 02/20/2018 06:42 AM ET)
Previous CloseC$22.00
Today's RangeC$19.73 - C$21.80
52-Week RangeC$6.81 - C$31.25
Volume775,262 shs
Average Volume1.01 million shs
Market CapitalizationC$2.04 billion
P/E Ratio1,020.00
Dividend YieldN/A
BetaN/A

About MedReleaf (TSE:LEAF)

MedReleaf logoMedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.

Receive LEAF News and Ratings via Email

Sign-up to receive the latest news and ratings for LEAF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
SymbolTSE:LEAF
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio1020
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC$0.02
Net IncomeN/A
Net Margins-21.65%
Return on Equity-6.38%
Return on Assets-5.47%

Miscellaneous

EmployeesN/A
Outstanding Shares99,145,000

MedReleaf (TSE:LEAF) Frequently Asked Questions

What is MedReleaf's stock symbol?

MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."

Where is MedReleaf's stock going? Where will MedReleaf's stock price be in 2018?

2 analysts have issued 12-month price targets for MedReleaf's shares. Their predictions range from C$20.00 to C$36.00. On average, they expect MedReleaf's share price to reach C$28.67 in the next year. View Analyst Ratings for MedReleaf.

Who are some of MedReleaf's key competitors?

Who are MedReleaf's key executives?

MedReleaf's management team includes the folowing people:

  • Eitan Popper, President (Age 35)
  • Neil Closner, Chief Executive Officer, Executive Director
  • Igor Gimelshtein, Chief Financial Officer, Corporate Secretary
  • Angelo Fefekos, Vice President - Clinical Affairs and Quality Compliance
  • Darren Karasiuk, Vice President - Strategy
  • Ivan Latysh, Vice President - Information Technology
  • Lloyd M. Segal, Non-Executive Chairman of the Board (Age 51)
  • Norma Beauchamp, Non-Executive Director
  • Ronald Funk, Non-Executive Director
  • Deborah E. Rosati, Non-Executive Director (Age 55)

How do I buy MedReleaf stock?

Shares of MedReleaf and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is MedReleaf's stock price today?

One share of MedReleaf stock can currently be purchased for approximately C$20.40.

How big of a company is MedReleaf?

MedReleaf has a market capitalization of C$2.04 billion.


MarketBeat Community Rating for MedReleaf (LEAF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedReleaf (TSE:LEAF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.502.503.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$28.67C$25.33C$20.00C$13.00
Price Target Upside: 36.05% upside6.86% downside20.41% upside41.15% upside

MedReleaf (TSE:LEAF) Consensus Price Target History

Price Target History for MedReleaf (TSE:LEAF)

MedReleaf (TSE:LEAF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/14/2018Canaccord GenuityBoost Price TargetBuyC$21.50 -> C$30.00View Rating Details
1/8/2018CowenBoost Price TargetC$20.00 -> C$36.00View Rating Details
11/15/2017Eight CapitalBoost Price TargetBuyC$13.00 -> C$20.00View Rating Details
(Data available from 2/20/2016 forward)

Earnings

Earnings History for MedReleaf (TSE:LEAF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

MedReleaf (TSE:LEAF) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MedReleaf (TSE:LEAF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

MedReleaf (TSE LEAF) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for MedReleaf (TSE:LEAF)

MedReleaf (TSE LEAF) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2018Stephen ArbibInsiderSell36,600C$18.01C$659,166.00
2/6/2018Stephen ArbibInsiderSell50,600C$18.00C$910,800.00
1/29/2018Olam Ltd. TikunInsiderSell1,000,000C$22.02C$22,020,000.00
1/25/2018Olam Ltd. TikunInsiderSell28,600C$25.00C$715,000.00
1/23/2018Olam Ltd. TikunInsiderSell29,300C$25.00C$732,500.00
8/24/2017Stephen ArbibInsiderSell100C$8.10C$810.00
8/23/2017Stephen ArbibInsiderSell10,000C$8.10C$81,000.00
6/8/2017Stephen ArbibInsiderBuy800C$7.89C$6,312.00
(Data available from 1/1/2013 forward)

Headlines

MedReleaf (TSE LEAF) News Headlines

Source:
DateHeadline
MedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool CanadaMedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool Canada
www.fool.ca - February 16 at 3:18 PM
Pot Pharm: Booming Canada weed sector plots next-wave medicinesPot Pharm: Booming Canada weed sector plots next-wave medicines
www.reuters.com - February 16 at 6:31 AM
Pot Pharm - Booming Canada weed sector plots next-wave medicinesPot Pharm - Booming Canada weed sector plots next-wave medicines
finance.yahoo.com - February 16 at 6:31 AM
Recreational marijuana sales in Canada face fresh delaysRecreational marijuana sales in Canada face fresh delays
finance.yahoo.com - February 16 at 6:31 AM
MedReleaf (LEAF) PT Raised to C$30.00MedReleaf (LEAF) PT Raised to C$30.00
www.americanbankingnews.com - February 14 at 3:12 PM
MedReleaf Reports Third Quarter Fiscal 2018 ResultsMedReleaf Reports Third Quarter Fiscal 2018 Results
finance.yahoo.com - February 13 at 3:15 PM
MedReleaf Corp (LEAF) Insider Sells C$659,166.00 in StockMedReleaf Corp (LEAF) Insider Sells C$659,166.00 in Stock
www.americanbankingnews.com - February 12 at 6:30 PM
MedReleaf Corp. Launches Recreational Cannabis Brand: San Rafael 71 - The Motley Fool CanadaMedReleaf Corp. Launches Recreational Cannabis Brand: San Rafael '71 - The Motley Fool Canada
www.fool.ca - February 12 at 3:15 PM
Stephen Arbib Sells 50,600 Shares of MedReleaf Corp (LEAF) StockStephen Arbib Sells 50,600 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - February 9 at 3:30 PM
MedReleaf introduces first adult-use recreational cannabis brand: San Rafael 71 launches with cannabis-inspired beerMedReleaf introduces first adult-use recreational cannabis brand: San Rafael '71 launches with cannabis-inspired beer
finance.yahoo.com - February 9 at 3:15 PM
Marijuana can only go on sale in Canada months after law passed -ministerMarijuana can only go on sale in Canada months after law passed -minister
finance.yahoo.com - February 7 at 5:15 AM
MedReleaf receives Health Canada approval for cannabis oil softgel capsulesMedReleaf receives Health Canada approval for cannabis oil softgel capsules
finance.yahoo.com - February 6 at 3:15 PM
MedReleaf Corp. Announces Closing of Previously Announced OfferingMedReleaf Corp. Announces Closing of Previously Announced Offering
finance.yahoo.com - January 31 at 3:15 PM
Insider Selling: MedReleaf Corp (LEAF) Insider Sells 1,000,000 Shares of StockInsider Selling: MedReleaf Corp (LEAF) Insider Sells 1,000,000 Shares of Stock
www.americanbankingnews.com - January 30 at 3:12 PM
Tikun Olam Announces Holdings in MedReleaf CorporationTikun Olam Announces Holdings in MedReleaf Corporation
finance.yahoo.com - January 30 at 3:11 PM
MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 28,600 SharesMedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 28,600 Shares
www.americanbankingnews.com - January 29 at 3:14 PM
MedReleaf Corp. to Host Third Quarter Fiscal 2018 Conference CallMedReleaf Corp. to Host Third Quarter Fiscal 2018 Conference Call
finance.yahoo.com - January 29 at 3:13 PM
Cannabis Stocks Begin To Reflect The Real IndustryCannabis Stocks Begin To Reflect The Real Industry
finance.yahoo.com - January 28 at 3:15 PM
Better Marijuana Stock: Aphria vs. MedReleaf -- The Motley Fool - Motley FoolBetter Marijuana Stock: Aphria vs. MedReleaf -- The Motley Fool - Motley Fool
www.fool.com - January 28 at 5:16 AM
MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 29,300 SharesMedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 29,300 Shares
www.americanbankingnews.com - January 25 at 9:28 PM
Make it or Break it: Here are 3 of the Most Exciting Stocks Available TodayMake it or Break it: Here are 3 of the Most Exciting Stocks Available Today
www.fool.ca - January 25 at 3:12 PM
BMO Open to More Pot Deals If Firms Pass Banks Tests, CEO Says - BloombergBMO Open to More Pot Deals If Firms Pass Bank's Tests, CEO Says - Bloomberg
www.bloomberg.com - January 25 at 3:12 PM
Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling - BenzingaCannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling - Benzinga
www.benzinga.com - January 25 at 5:15 AM
Its High Times for Pot Deals in Canada Ahead of Legalization - BloombergIt's High Times for Pot Deals in Canada Ahead of Legalization - Bloomberg
www.bloomberg.com - January 24 at 3:15 PM
MedReleaf Ready To Rumble: Positioned Well For Long-Term Growth - Seeking AlphaMedReleaf Ready To Rumble: Positioned Well For Long-Term Growth - Seeking Alpha
seekingalpha.com - January 23 at 3:17 PM
Before BMO led stock sale for marijuana grower, CIBC lent money - The Globe and MailBefore BMO led stock sale for marijuana grower, CIBC lent money - The Globe and Mail
www.theglobeandmail.com - January 20 at 3:18 PM
Standout Canadian Players Foster the Cannabis Lifestyle - PR Newswire (press release)Standout Canadian Players Foster 'the Cannabis Lifestyle' - PR Newswire (press release)
www.prnewswire.com - January 17 at 8:45 AM
BRIEF-Medreleaf Announces Upsize Of Previously Announced OfferingBRIEF-Medreleaf Announces Upsize Of Previously Announced Offering
www.reuters.com - January 9 at 5:58 PM
MedReleaf Corp. Announces Upsize of Previously Announced OfferingMedReleaf Corp. Announces Upsize of Previously Announced Offering
finance.yahoo.com - January 9 at 5:58 PM
MedReleaf (LEAF) PT Raised to C$36.00MedReleaf (LEAF) PT Raised to C$36.00
www.americanbankingnews.com - January 8 at 2:36 PM
California Legalization Has Canadian Pot Stocks SmokingCalifornia Legalization Has Canadian Pot Stocks Smoking
www.bloomberg.com - January 2 at 7:24 PM
Modern Leaf Partners with mdBriefCase Group Inc. and Advancing Practice; Secures Strategic Investment to Launch Cannabis Education and Proposed Ecommerce PlatformModern Leaf Partners with mdBriefCase Group Inc. and Advancing Practice; Secures Strategic Investment to Launch Cannabis Education and Proposed Ecommerce Platform
finance.yahoo.com - December 18 at 9:08 AM
Why it’s so difficult to bet against Canada’s marijuana boomWhy it’s so difficult to bet against Canada’s marijuana boom
www.theglobeandmail.com - December 15 at 9:17 AM
Why Its So Difficult to Bet Against Canadas Marijuana BoomWhy It's So Difficult to Bet Against Canada's Marijuana Boom
www.bloomberg.com - December 14 at 9:04 AM
Canada Gives Provinces Bigger Cut of Pot Tax From LegalizationCanada Gives Provinces Bigger Cut of Pot Tax From Legalization
www.bloomberg.com - December 12 at 9:26 AM
Ehave Expands into the Cannabis Industry -- CFN MediaEhave Expands into the Cannabis Industry -- CFN Media
finance.yahoo.com - December 5 at 9:22 AM
Eight Capital Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00Eight Capital Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00
www.americanbankingnews.com - November 15 at 3:00 PM
Canopy Growth’s second-quarter loss dampens marijuana stock rallyCanopy Growth’s second-quarter loss dampens marijuana stock rally
www.theglobeandmail.com - November 15 at 4:03 AM
BRIEF-Medreleaf announces $100.5 mln bought deal financingBRIEF-Medreleaf announces $100.5 mln bought deal financing
www.reuters.com - November 15 at 4:03 AM
MedReleafs Australian joint venture partner receives medical cannabis cultivation and production license from the Australian Office of Drug ControlMedReleaf's Australian joint venture partner receives medical cannabis cultivation and production license from the Australian Office of Drug Control
finance.yahoo.com - November 15 at 4:03 AM
Canaccord Genuity Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00Canaccord Genuity Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00
www.americanbankingnews.com - November 14 at 2:30 PM
MedReleaf Reports Second Quarter Fiscal 2018 ResultsMedReleaf Reports Second Quarter Fiscal 2018 Results
finance.yahoo.com - November 13 at 12:54 PM
Science Catches Up with Cannabis: New Genetic Test Empowers Physicians to Prescribe Medical Cannabis with ConfidenceScience Catches Up with Cannabis: New Genetic Test Empowers Physicians to Prescribe Medical Cannabis with Confidence
finance.yahoo.com - November 11 at 4:21 PM
MedReleaf receives license amendment from Health Canada to commence sales at its Bradford FacilityMedReleaf receives license amendment from Health Canada to commence sales at its Bradford Facility
finance.yahoo.com - November 6 at 3:15 PM
Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal - PR Newswire (press release)Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal - PR Newswire (press release)
www.prnewswire.com - November 2 at 5:14 AM
Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake PortalEhave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal
finance.yahoo.com - November 2 at 5:14 AM
Why MedReleaf Corp. Could Become a Leader in Canada’s Growing Medicinal Marijuana MarketWhy MedReleaf Corp. Could Become a Leader in Canada’s Growing Medicinal Marijuana Market
www.fool.ca - November 1 at 5:21 AM
3 Small-Cap Marijuana Stocks to Get on Your Radar - Motley Fool3 Small-Cap Marijuana Stocks to Get on Your Radar - Motley Fool
www.fool.com - October 29 at 7:15 PM
MedReleaf Corp. to Host Second Quarter Fiscal 2018 Conference CallMedReleaf Corp. to Host Second Quarter Fiscal 2018 Conference Call
finance.yahoo.com - October 28 at 7:36 AM
Roots Slumps on Trading Debut as Canadiana Proves Hit and Miss - BloombergRoots Slumps on Trading Debut as Canadiana Proves Hit and Miss - Bloomberg
www.bloomberg.com - October 26 at 5:10 PM

SEC Filings

MedReleaf (TSE:LEAF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

MedReleaf (TSE LEAF) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.